Graft Polymer (UK) PLC Directorate Change
12 August 2024 - 7:21PM
RNS Regulatory News
RNS Number : 0877A
Graft Polymer (UK) PLC
12 August 2024
12 August
2024
Graft Polymer (UK)
Plc
("Graft Polymer" or the
"Company")
Director
resignation
Graft Polymer (UK) Plc (LON: GPL),
an innovative biopolymer drug delivery systems development company,
announces the resignation, with immediate effect, of Yifat Steuer
from its board of directors and from the role of Chief Financial
Officer.
Orana Corporate LLP will continue to
provide support in relation to the Company's financial function
whilst the Company proceeds to select a new CFO.
Nicholas Nelson, Chairman, commented:
"Yifat departs us with our sincere thanks for all she has done
during the transitionary period since I became Chairman. She has
provided us with invaluable guidance and
professionalism.
"New board appointments are planned to steer the Company as it
pursues its mission to innovate in drug delivery solutions.
"
Enquiries:
Graft Polymer (UK) Plc
Anthony Tennyson, CEO and Executive Director
Email: anthonytennyson@graftpolymer.co.uk
Allenby Capital (Broker)
Nick Naylor
/ Liz Kirchner (Corporate Finance) | Guy McDougall
(Sales)
+44 (0) 20 3328
5656
About Graft Polymer (UK) Plc
Graft Polymer plc ("Graft Polymer")
(LON: GPL) is an innovative biopolymer drug delivery systems
development company dedicated to enabling biopharmaceutical
companies to enhance the effectiveness of their therapeutics. Our
proprietary platform, a bioabsorbable self-nanoemulsifying drug
delivery system (SNEDDS), represents a cutting-edge solution in
drug delivery technology. By integrating active pharmaceutical
ingredients (APIs) into our novel, patented delivery systems, we
enable clients to improve the pharmacokinetics, bioavailability,
and stability of their therapeutics.
For more information, please visit
www.graftpolymer.co.uk.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
BOAGCGDIGDBDGSD
Graft Polymer (uk) (LSE:GPL)
Historical Stock Chart
From Nov 2024 to Dec 2024
Graft Polymer (uk) (LSE:GPL)
Historical Stock Chart
From Dec 2023 to Dec 2024
